During the past decade, Guardant Health conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Guardant Health" are "Advanced Breast Cancer" (1 trials) and "Non-Hematologic Malignancy" (1 trials). Many other conditions were trialed in "Guardant Health" in a lesser frequency.

Most popular intervention types in "Guardant Health" are "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Guardant360 test" (1 trials). Other intervention names were less common.

The vast majority of trials in "Guardant Health" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Guardant Health". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Guardant Health, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Guardant Health, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".